FDA Panel Recommends Pfizer's COVID Vaccine For Kids Ages 5 -11 Shots could be offered as early as next week. 👏👏
The New York Times
The Centers for Disease Control and Prevention has its own panel scheduled for next week. The FDA’s panel voting means the CDC panel is next to weigh in on the safety of the vaccine for kids.
Offit said, “The question is when do you know enough? And I think we certainly know that there are many children between 5 and 11 years of age who are susceptible to this disease who could very well be sick and are hospitalized or die from it.”
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 live updates: FDA panel hours away from vote on Pfizer vaccine for kidsAn independent FDA advisory panel will debate and vote on whether to authorize the Pfizer vaccine for children ages 5 to 11. The nonbinding vote is expected between 4:30 p.m. and 5 p.m. ET today.
Read more »
FDA panel OKs low-dose Pfizer vaccine for kids 5 to 11The move, if signed off on by the FDA, would expand eligibility to 28 million children in the U.S.
Read more »
FDA advisory panel OKs Pfizer vaccine for kids 5 to 11A Covid vaccine for kids passed its first regulatory hurdle. A FDA panel voted to authorize the Pfizer Covid vaccine for children. The vote now goes to the FDA.
Read more »
U.S. FDA advisers weigh Pfizer/BioNTech COVID-19 vaccine in childrenAn expert panel will weigh authorization of Pfizer Inc and BioNTech's COVID-19 vaccine for U.S. children aged 5 to 11 on Tuesday as it prepares to vote on a recommendation for the federal Food and Drug Administration.
Read more »